Extraneal and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Extraneal (icodextrin) and Lactulose (lactulose). Common drug interactions include skin burning sensation among females and peritonitis among males.

The phase IV clinical study analyzes what interactions people have when they take Extraneal and Lactulose. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Extraneal?

Extraneal has active ingredients of icodextrin. eHealthMe is studying from 32,994 Extraneal users. Check the latest studies of Extraneal.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.



On Jul, 12, 2026

61 people who take Extraneal and Lactulose together, and have interactions are studied.

Extraneal and Lactulose drug interactions.

What are the common drug interactions of Extraneal and Lactulose, by gender? *:

female:

  1. Skin burning sensation
  2. Dyspnoea (difficult or laboured respiration)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Death
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Cardiac arrest
  7. Abdominal pain
  8. Circulatory collapse
  9. Peritoneal haemorrhage (peritoneal bleeding)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

male:

  1. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  2. Abdominal distension
  3. General physical health deterioration (weak health status)
  4. Hip fracture
  5. Hypokalaemia (low potassium)
  6. Blood albumin decreased
  7. Dyspnoea (difficult or laboured respiration)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Arthralgia (joint pain)
  10. Drug hypersensitivity

What are the common drug interactions of Extraneal and Lactulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Catheter site haemorrhage (bleeding at catheter site)
  3. Chest discomfort
  4. Chills (felling of cold)
  5. Dizziness
  6. Abdominal pain
  7. Bloody peritoneal effluent
  8. Muscle haemorrhage (bleeding in muscle)
  9. Soft tissue injury

30-39:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

40-49:

  1. Abdominal distension
  2. Diarrhoea
  3. Anxiety
  4. Body temperature fluctuation
  5. Deformity (disfigurement)
  6. Drug hypersensitivity
  7. Eczema asteatotic (severe dry skin- during the winter months and in the elderly)
  8. Hyperkeratosis (thickening of the outer layer of the skin)
  9. Leukocytosis (increased white blood cells)
  10. Nail ridging (nail has raised ridges and is thin and curved inward)

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Peritoneal haemorrhage (peritoneal bleeding)
  3. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Type 2 diabetes mellitus
  6. Vomiting
  7. Abdominal pain upper
  8. Intestinal ulcer perforation (holes in intestine wall due to intestinal ulcer)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Peritoneal dialysis complication

60+:

  1. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  2. Death
  3. Blood albumin decreased
  4. Cardiac arrest
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Arthralgia (joint pain)
  7. Endocarditis (inflammation in heart muscle)
  8. Fall
  9. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Chronic Renal Failure (kidney failure): 8 people, 13.11%
  2. Asthma: 5 people, 8.20%

* Approximation only. Some reports may have incomplete information.

Do you take Extraneal and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Extraneal and Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Extraneal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Extraneal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on icodextrin and lactulose (the active ingredients of Extraneal and Lactulose, respectively), and Extraneal and Lactulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: